Standard physical therapy relies on outdated protocols. We use the same advanced technology and neural methodology trusted by NFL superstars and Olympic athletes to accelerate recovery and eliminate atrophy.
After an ACL injury or surgery, the nervous system changes fast — muscles shut down, movement patterns fade, and natural activation becomes harder to access. Recovery isn't just physical; it's neurological.
The Volta X is built for that moment.
This next-generation direct current system supports the essentials of recovery across early, mid, and late stages: muscle activation, neuromuscular re-education, improved local circulation, and maintaining or improving range of motion.
Engineered for mobility, the Volta X delivers the kind of portability and power usually found only in much larger systems — all in a sleek, travel-ready, carry-on friendly design.
Used within its FDA-cleared indications and paired with our ACL-specific training, the Volta X helps counter post-surgical shutdown and keeps you connected to your recovery when it matters most.
This is direct current, redefined.
After an ACL tear, your brain literally "unplugs" the connection to your quad to protect the joint. Neural mapping is the process of finding exactly where those connections are broken and "replugging" them using precise stimulus and movement patterns.
Blood Flow Restriction (BFR) training is the "cheat code" for the first 3 months of recovery. It allows us to trigger a massive hypertrophy (muscle building) response using only 20% of standard weight loads — meaning you build muscle without stressing your healing graft.
*Based on internal data comparing quad circumference measurements in athletes using Accelerate ACL program vs. traditional PT-only programs. Individual results vary. Not medical advice. Accelerate ACL supplements — does not replace — physical therapy and medical care prescribed by your healthcare provider.
The Volta X is FDA-cleared for neuromuscular re-education. Consult your physician before beginning any recovery program.